Inactive Instrument

Stentys

Equities

STNT

FR0010949404

Medical Equipment, Supplies & Distribution

STENTYS Announces Revenues Results for the Fourth Quarter and Full Year 2015

January 13, 2016 at 10:15 pm IST

STENTYS announced revenues results for the fourth quarter and full year 2015. For the quarter, the company reported revenues of EUR 1,880,460 against EUR 1,038,700 a year ago.

For the year, the company reported revenues of EUR 6,102,060 against EUR 3,851,100 a year ago.

Latest news about Stentys

Stentys S.A. Reports Earnings Results for the Half Year Ended June 30, 2020	08/20/08	CI
STENTYS S.A. Announces Revenue Results for the First Quarter Of 2020	15/20/15	CI
Stentys Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2019	14/19/14	CI
Stentys S.A. Announces Revenue Results for the First Quarter 2019	11/19/11	CI
Stentys Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2018	01/19/01	CI
Stentys S.A. Announces Audited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2018	10/19/10	CI
STENTYS S.A. Announces Consolidated Revenue Results for the Third Quarter and Nine Months Ended September 30, 2018	11/18/11	CI
STENTYS Announces Earnings Results for the Six Months Ended June 30, 2018	28/18/28	CI
STENTYS S.A. Announces Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2018	11/18/11	CI
STENTYS S.A. completed the acquisition of Minvasys.	30/18/30	CI
STENTYS S.A. Reports Revenue Results for the First Quarter Ended March 31, 2018	12/18/12	CI
STENTYS S.A. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2017	03/18/03	CI
STENTYS S.A. entered into an exclusive negotiations agreement to acquire Minvasys for €7.4 million.	30/18/30	CI
STENTYS S.A. Announces Unaudited Revenue Results for the Fourth Quarter and Full Year of 2017	08/18/08	CI
STENTYS S.A. Announces the Pre-Commercialization of SERPENTIS, Its New Latest-Generation of Active Stent	08/17/08	CI
STENTYS S.A. Announces Unaudited Revenue Results for the Third Quarter and First Nine Months Ended September 30, 2017	12/17/12	CI
STENTYS S.A. Announces Earnings Results for the Six Months Ended June 30, 2017	02/17/02	CI
STENTYS S.A. Announces Unaudited Revenue Results for the Second Quarter and First Half of 2017	12/17/12	CI
STENTYS S.A. cancelled the transaction announced on May 14, 2014	14/17/14	CI
STENTYS S.A. Announces Revenue Results for the First Quarter Ended March 31, 2017	24/17/24	CI
STENTYS S.A. Announces Executive Changes	21/17/21	CI
STENTYS S.A. Reports Earnings Results for the Year Ended December 31, 2016	21/17/21	CI
STENTYS Reports Revenue Results for the Fourth Quarter and Full Year of 2016	12/17/12	CI
STENTYS Announces Revenue Results for the Third Quarter and Nine Months Ended September 30, 2016	12/16/12	CI
STENTYS Announces Consolidated Earnings Results for the Half-Year Ended June 30, 2016	15/16/15	CI

Chart Stentys

Duration

Period

More charts

Company Profile

Stentys SA is a French-based company specialized in the development of a new generation of stents for the treatment of acute myocardial infarction or coronary artery disease. It's main product STENTYS Stent, self-expanding coronary bare-metal stent system, is indicated for the treatment of Acute Coronary Syndrome. The Company's institutional shareholders are Sofinnova Partners, Credit Agricole Private Equity and Scottish Equity Partners. In June 2014, it acquired Cappella Peel Away Inc.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-5.50%	18TCr
MEDTRONIC PLC	-5.79%	9.95TCr
BECTON, DICKINSON AND COMPANY	-6.59%	6.58TCr
DEXCOM, INC.	-8.38%	4.52TCr
CENCORA, INC.	+8.42%	4.39TCr
HOYA CORPORATION	+10.10%	4.22TCr
METTLER-TOLEDO INTERNATIONAL, INC.	+10.97%	2.87TCr
TERUMO CORPORATION	+18.89%	2.54TCr
WEST PHARMACEUTICAL SERVICES, INC.	-8.39%	2.35TCr

Other Medical Equipment, Supplies & Distribution